Abstract
Major emerging markets such as India, China, and Brazil, in addition to presenting rising middle-class populations, are now playing a part in driving the transformation of the health-care sector, from R&D and clinical trials to local manufacturing.
Chapter PDF
Similar content being viewed by others
Keywords
- World Trade Organization
- Foreign Firm
- Purchase Power Parity
- Universal Health Coverage
- Intellectual Property Protection
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abuduxike, A. and Aljunid, S. (2012). “Development of Health Biotechnology in Developing Countries: Can Private-Sector Players Be the Prime Movers?” Biotechnology Advances, 30: 1589–601.
Biocon (2015). Biocon company data, Company History. Retrieved from http://www.biocon.com/biocon_invrelation_com_history.asp.
Booz & Company. (2011). “Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry.” Booz & Company. Retrieved from http://www.strategyand.pwc.com/global/home/what-we-think/reports-white-papers/article-display/pharma-emerging-markets
Burns, L. (ed.). (2014). India’s Healthcare Industry. Cambridge: Cambridge University Press.
Daemmrich, A. and McKown Cornell, I. (2012). “GlaxoSmithKline in Brazil: Public/Private Vaccine Partnership,” Harvard Business School, Case 9–712–049, June.
Fabre, G. (2014). “The Real Leap Forward: China’s Ramp;D and Innovation Strategy.” In Taylor, R. (ed.) The Globalization of Chinese Business. Implications for Multinational Investors (pp. 3–25 ). Oxford, UK: Elsevier/Chandos Publishing.
Frew, S. (2014). “India’s Biotechnology Sector.” In Burns, L. (ed.) India’s Healthcare Industry (pp. 477–99 ). Cambridge: Cambridge University Press.
Gragnolati, M., Lindelow, M., and Couttolenc, B. (2012). Twenty Years of Health System Reform in Brazil–An Assessment of the Sistema Unico de Saude. Washington, DC: World Bank.
Herzlinger, R. and Kindred, N. (2014). “Shanghai Pharmaceuticals.” Harvard Business School, Case 9–313–016, 2014.
IBEF (India Brand Equity Foundation). (2014). “Biotechnology Industry in India.” Retrieved from http://www.ibef.org/
IMS Institute for Healthcare Informatics. (2013). “The Global Use of Medicines: Outlook through 2017.” Retrieved from http://www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22a/?vgnextoid=9f819e464e832410VgnVCM10000076192ca2RCRD&vgnextchannel=a64de5fda6370410VgnVCM10000076192ca2RCRD
IMS Institute for Healthcare Informatics. (2014). “Harbingers of Change in Healthcare.” Retrieved from http://www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22a/?vgnextoid=af47009812568410VgnVCM10000076192ca2RCRD&vgnextchannel=a64de5fda6370410VgnVCM10000076192ca2RCRD
La Forgia, G. and Nagpal, S. (2012). Government-Sponsored Health Insurance in India–Are You Covered? Washington, DC: World Bank.
Lawton R. B. (ed.) (2014), India’s Healthcare Industry. Cambridge: Cambridge University Press.
Li, Y., Lu, J., Tao, Z., and Wei, S -J. (2010). Viagra in China: A Prolonged Battle over Intellectual Property Rights. Asia Case Research Centre, University of Hong Kong, Case HKU902.
Lima, M. (2015). “Brazil Analysts Raise Inflation, Cut GDP Forecast for Third Week.” Bloomberg News. Retrieved from http://www.bloomberg.com/news/2015–01–19/brazil–analysts–raise–inflation–cut–gdp–forecast–for–third–week.html
MOITI (Massachusetts Office of International Trade and Investment). (2008). “Brazil Biotechnology Industry.” Retrieved from http://kooperation-international.de/fileadmin/public/cluster/Belo_Horizonte/BrazilBiotechnologyIndustry_Mass.pdf
Morel, C. M., Tara, A., Denis, B., et al. (2005). “Health Innovation Networks to Help Developing Countries Address Neglected Diseases.” Science, 309 (5733): 401–4.
Mori Sarti, F., Ivanauskas, T., Montoya Diaz, M., and Coelho Campino, A. C. (2012). Towards Universal Health Coverage in Latin America and the Caribbean: Case Study Measuring Inequalities in Health in Brazil. Washington, DC: World Bank.
Resende, V. (2012). The Biotechnology Market in Brazil. Washington, DC: US Department of Commerce.
Sachan, N., Tathambothia, A., Nehru, R., and Dharanaj, C. (2013). Collaborative Commercialization at Gilead Sciences: Resolving the Innovation vs. Access Tradeoff. Indian School of Business, Case ISB 025, 2013.
Specter, M. (2014). “The Gene Factory.” The New Yorker. Retrieved from http://www.newyorker.com/magazine/2014/01/06/the-gene-factory
Tao, Z. (2014). The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets. Asia Case Research Centre, University of Hong Kong, Case HK 1049.
Tyagi, S., Mahajan, V., and Nauriyal, D. K. (2014). “Innovations in the Indian Drug and Pharmaceutical Industry: Have They Impacted Exports?” Journal of Intellectual Property Rights, 19: 243–52. Retrieved from http://nopr.niscair.res.in/handle/123456789/29286
Wang, K., Hong, J., Marinova, D., and Zhu, L. (2009). “Evolution and Governance of the Biotechnology and Pharmaceutical Industry in China.” Mathematics and Computers in Simulation, 79 (9): 2947–56.
World Bank. (2013). Brazil Report, 2013. Washington, DC: World Bank.
World Health Organization. (2013). World Health Report 2013. Geneva: Research for Universal Health Coverage.
Yu, X., Li, C., Shi, Y., and Yu, M. (2010). “Pharmaceutical Supply Chain in China: Current Issues and Implications for Health System Reform.” Health Policy, 97 (1): 8–15.
Editor information
Editors and Affiliations
Copyright information
© 2016 Françoise Simon
About this chapter
Cite this chapter
Simon, F. (2016). Health-Care Innovation in Emerging Markets. In: Haar, J., Ernst, R. (eds) Innovation in Emerging Markets. International Political Economy Series. Palgrave Macmillan, London. https://doi.org/10.1057/9781137480293_13
Download citation
DOI: https://doi.org/10.1057/9781137480293_13
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-69390-0
Online ISBN: 978-1-137-48029-3
eBook Packages: Political Science and International StudiesPolitical Science and International Studies (R0)